KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Finished Goods (2016 - 2025)

Historic Finished Goods for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $9.5 million.

  • CareDx's Finished Goods rose 7549.22% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 7549.22%. This contributed to the annual value of $4.8 million for FY2024, which is 3173.87% up from last year.
  • According to the latest figures from Q3 2025, CareDx's Finished Goods is $9.5 million, which was up 7549.22% from $8.4 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Finished Goods ranged from a high of $9.5 million in Q3 2025 and a low of $2.4 million during Q1 2021
  • Moreover, its 5-year median value for Finished Goods was $3.7 million (2023), whereas its average is $4.2 million.
  • Examining YoY changes over the last 5 years, CareDx's Finished Goods showed a top increase of 12978.85% in 2021 and a maximum decrease of 4682.91% in 2021.
  • Quarter analysis of 5 years shows CareDx's Finished Goods stood at $3.9 million in 2021, then fell by 24.26% to $3.0 million in 2022, then grew by 23.5% to $3.7 million in 2023, then surged by 31.74% to $4.8 million in 2024, then skyrocketed by 97.92% to $9.5 million in 2025.
  • Its last three reported values are $9.5 million in Q3 2025, $8.4 million for Q2 2025, and $4.4 million during Q1 2025.